title: Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract.
authors.affiliation: Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
authors.forename: M R
authors.initials: MR
authors.lastname: Spitz
authors.forename: S M
authors.initials: SM
authors.lastname: Lippman
authors.forename: H
authors.initials: H
authors.lastname: Jiang
authors.forename: J J
authors.initials: JJ
authors.lastname: Lee
authors.forename: F
authors.initials: F
authors.lastname: Khuri
authors.forename: T C
authors.initials: TC
authors.lastname: Hsu
authors.forename: Z
authors.initials: Z
authors.lastname: Trizna
authors.forename: S P
authors.initials: SP
authors.lastname: Schantz
authors.forename: S
authors.initials: S
authors.lastname: Benner
authors.forename: W K
authors.initials: WK
authors.lastname: Hong
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000235:genetics*; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D015474:Isotretinoin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009153:Mutagens / Q000494:pharmacology*; D016016:Proportional Hazards Models; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013723:Teratogens / Q000494:pharmacology; D017211:Treatment Failure
chemical_list: D000964:Antimetabolites, Antineoplastic; D009153:Mutagens; D013723:Teratogens; D001761:Bleomycin; D015474:Isotretinoin